CAPR
Capricor Therapeutics Inc
NASDAQ: CAPR · HEALTHCARE · BIOTECHNOLOGY
$33.58
+3.45% today
Updated 2026-04-30
Market cap
$2.04B
P/E ratio
—
P/S ratio
124.43x
EPS (TTM)
$-2.26
Dividend yield
—
52W range
$4 – $40
Volume
1.3M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D8.3
Valuation
A—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$54.67
+62.81%
12-Month target
—
—
Intrinsic (DCF)
$55.12
Margin of safety
+56.10%
2 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 56.10% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-28.69M
- Revenue declining -7.90% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.55M | $25.18M | $22.27M | $0.00 | $11.13M |
| Net income | $-29.02M | $-22.29M | $-40.47M | $-105.04M | $-30.17M |
| EPS | — | — | — | — | $-2.26 |
| Free cash flow | $1.56M | $-27.64M | $-41.53M | $-72.72B | $-28.69M |
| Profit margin | -1,137.37% | -88.52% | -181.71% | — | — |
Peer comparison
Smart narrative
Capricor Therapeutics Inc trades at $33.58. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $11.13M. Our DCF model estimates intrinsic value at $55.12.
Frequently asked questions
What is Capricor Therapeutics Inc's stock price?
Capricor Therapeutics Inc (CAPR) trades at $33.58.
Is Capricor Therapeutics Inc overvalued?
Smart Value Score 31/100 (Grade F, Strong Sell). DCF value $55.12.
What is the price target of Capricor Therapeutics Inc (CAPR)?
The analyst target price is $54.67, representing +62.8% upside from the current price of $33.58.
What is the intrinsic value of Capricor Therapeutics Inc (CAPR)?
Based on our DCF model, intrinsic value is $55.12, a +56.1% margin of safety versus $33.58.
What is Capricor Therapeutics Inc's revenue?
TTM revenue is $11.13M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio124.43x
ROE-46.60%
Beta0.48
50D MA$30.24
200D MA$17.19
Shares out0.06B
Float0.05B
Short ratio—
Avg volume1.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—